Janssen Sciences builds Irish biomanufacturing facility

The Ringaskiddy, Co. Cork site’s production footprint has been expanded by 19,100 sqm, creating 200 new full-time jobs

Photo from Janssen Sciences twitter: Remo Colarusso Vice President of Janssen Supply Chain at Johnson & Johnson (Far left); Simon Coveney TD, An Tánaiste and Minister for Foreign Affairs & Trade (Second from left); Kathy Wengel, Executive VP and Chief Global Supply Chain Officer at Johnson & Johnson (Centre); Martin Shanahan, CEO of IDA Ireland (Far right)

Janssen Sciences Ireland UC, part of the Johnson & Johnson family of companies, has officially opened its new manufacturing building in Ringaskiddy, Co. Cork. The company expanded operations on its 40-hectare biopharmaceutical supply chain site in Ringaskiddy, which it has run since 2005.

The expansion of the biomanufacturing site increases the company's production capacity by an additional 19,100 sqm and creates 200 new full-time jobs. Approximately 450 people were employed on-site during the two-year construction project.

The official opening ceremony for the facility was attended by Simon Coveney TD, An Tánaiste and Minister for Foreign Affairs & Trade, Kathy Wengel, Executive VP and Chief Global Supply Chain Officer at Johnson & Johnson, and Martin Shanahan, CEO of IDA Ireland.

Speaking at the event, Coveney explained that in 2018 alone, 33% of Ireland's total exports were pharmaceutical and medical products, with Johnson & Johnson featuring as one of our single largest exporters.

Johnson & Johnson's Wengel, said: "Our Ringaskiddy facility is an important part of our global manufacturing network and expanding our capabilities here will allow us to pursue innovative solutions that advance how medicines are manufactured so that we can be at the forefront of treating, preventing, intercepting and curing some of the world's most devastating and complex diseases."

Companies